OverT Bio Secures $16M to Optimize Cell Therapy for Solid Tu

What You Should Know:  - OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing

Related Keywords

Alexandria , Al Iskandariyah , Egypt , Neville Sanjana , Cancer Research Institute , Fusion Fund , Overt Bio Secures , Optimize Cell Therapy , Should Know , Overt Bio , Alexandria Venture Investments , Civilization Ventures , Cancer Research , Data Driven Approach , Cell Therapy , Mat Legut , Pioneering Technologies , Parallel Genetic Screening , Cell Multiomics , Biology Techniques ,